Insider Selling: NIOX Group (LON:NIOX) Insider Sells £3,609.60 in Stock

by · The Cerbat Gem

NIOX Group Plc (LON:NIOX – Get Free Report) insider Nicholas Mills sold 4,512 shares of NIOX Group stock in a transaction on Tuesday, October 27th. The shares were sold at an average price of GBX 80, for a total value of £3,609.60.

NIOX Group Price Performance

LON NIOX opened at GBX 64 on Friday. NIOX Group Plc has a fifty-two week low of GBX 53.84 and a fifty-two week high of GBX 80. The stock’s 50-day moving average is GBX 67.09 and its two-hundred day moving average is GBX 63.06. The firm has a market cap of £259.35 million, a P/E ratio of 39.26 and a beta of 0.92. The company has a debt-to-equity ratio of 1.06, a current ratio of 4.60 and a quick ratio of 1.94.

NIOX Group (LON:NIOX – Get Free Report) last announced its earnings results on Wednesday, September 30th. The company reported GBX 1.41 earnings per share for the quarter. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%. On average, analysts anticipate that NIOX Group Plc will post 1.17 earnings per share for the current fiscal year.

NIOX Group Company Profile

(Get Free Report)

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.

Recommended Stories